Form 4: Pfizer Executive Vice President Acquires Phantom Stock Units

Pfizer's Executive Vice President, Rady A. Johnson, acquired 8 phantom stock units through the company's Supplemental Savings Plan.

Summary

• Rady A. Johnson, an Executive Vice President at Pfizer, acquired 8 phantom stock units on November 15, 2024.
• These units were acquired through the Pfizer Supplemental Savings Plan.
• Each unit represents one phantom share of Pfizer common stock.
• The units will be settled in cash following Johnson's separation from service.
• Johnson can transfer these units into an alternative investment account at any time.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation, which is generally viewed neutrally to slightly positive as it aligns executive interests with company performance.

Positives

• The acquisition of phantom stock units aligns the executive's interests with the company's performance.
• The Supplemental Savings Plan provides a mechanism for executives to accumulate wealth tied to the company's stock.

Industry Context

This is a routine filing related to executive compensation and is common practice for publicly traded companies.

Comparison to Industry Standards

• Many large pharmaceutical companies use similar stock-based compensation plans for their executives.
• Phantom stock units are a common tool to align executive interests with shareholder value.
• The Pfizer Supplemental Savings Plan is similar to other deferred compensation plans offered by peer companies.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns executive interests with company performance.

Key Dates

Keywords

Pfizer, phantom stock units, executive compensation, Supplemental Savings Plan, insider trading, Form 4, Rady A. Johnson